| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |